Table 3 Clinical and sexual parameters of subjects with PE + DM and normal group based on Androgen receptor (GGC)n repeats
Subjects with PE + DM n = 250 | Control subjects n = 125 | |||||
|---|---|---|---|---|---|---|
GGC Long stretches (≥26) n = 42 | GGC Medium stretches (22–25) n = 110 | GGC short stretches (≤21) n = 98 | GGC Long stretches (≥26) n = 31 | GGC Medium stretches (22–25) n = 79 | GGC short stretches (≤21) n = 40 | |
Clinical Parameter | ||||||
Age (years) | 45 (35–55) | 43.5 (32–58) | 45 (30–60) | 45 (30–60) | 46 (32–60) | 45 (30–60) |
BMI (Kg/m2) | 32.45 (30.8–34.1) | 32.25 (30.5–34.0) | 31 (30–32) | 31.25 (28.9–33.6) | 30.8 (27.9–33.7) | 31.9 (28.85–35.01) |
Blood Sampling Time (8–10 Am) | 9.50 (9.00–10 | 9.57 (9.15–10) | 8.72 (8.15–9.30) | 9.00 (8.00–10) | 8.65 (8.00–9.30) | 8.80 (8.30–9.30) |
Diabetes duration (years) | 9.3 (4.21–14.56) | 7.85(2.2–13.5) | 8.30 (4.5–12.1) | 9.67 (6.37–12.98) | 8.4 (4.4–12.5) | 7.5 (3.3–11.8) |
HbA1C (%) | 7.05 (6.2–7.9)* | 7.2 (6.4–8.00)* | 7.1 (6.3–7.9)* | 4.2 (3.9–4.6) | 4.1 (3.7–4.5) | 4.1 (3.4–4.9) |
Hormonal Assays | ||||||
Oxytocin (pg/ml) | 79.1 (51.9–106.3) | 82.85 (65.9–99.8) | 83.8 (68.4–97.8) | 79.35 (76.5–82.2) | 80 (78.9–81.1) | 79.5 (77.9–81.2) |
Prolactin (ng/ml) | 5.00 (4.01–5.98) | 5.11 (4.34–5.95) | 5.01 (4.1–6.00) | 7.2 (5.6–8.99) | 7.1 (5.8–8.50) | 6.95 (4.9–8.96) |
Total Testosterone (ng/ml) | 4.9 (3.8–5.9) | 4.8 (4.4–5.36) | 4.8 (3.8–5.8) | 5.1 (3.4–6.9) | 4.1 (3.9–4.4) | 4.9 (4.1–5.8) |
TSH (mIU/L) | 2.7 (2.5–2.9) | 2.5 (2.1–2.9)0 | 3.0 (2.5–3.5) | 2.9 (2.1–3.8) | 3.1 (2.5–3.8) | 2.9 (2.1–3.8) |
Premature Ejaculation Assessments | ||||||
PEDT | 22.5 (20–25.1)* | 21.9 (17.8–26)* | 21.3 (16.8–25.9)* | 7.7 (6.57–9.00) | 7.4 (6.8–8.19) | 7.6 (6.2–9.00) |
Self-estimated IELT (s) | 168 (156–180)* | 170 (165–175)* | 168 (158–178)* | 344 (201–488) | 342 (224–460) | 343 (250–436) |
Depression Assessments | ||||||
BDI-II | 49 (40–58)* | 48 (38–58)* | 51 (42–60)* | 10 (7–13) | 11 (9–13) | 11 (9–13) |
Sexual Assessments | ||||||
EF | 29.5 (29–30) | 29.5 (29–30) | 27 (26–28) | 27 (26–28) | 26.5 (26–27) | 26.5 (26–27) |
OR | 3 (1–5) | 3 (1–5) | 5 (3–7) | 5 (3–7) | 6 (3–9) | 6 (3–9) |
SD | 7 (6–8) | 8 (7–9) | 5 (1–9) | 5 (1–9) | 6 (4–8) | 6 (4–8) |
OS | 4.5 (3–6) | 4.5 (3–6) | 6 (4–8) | 6 (4–8) | 4.5 (3–6) | 4.5 (3–6) |
IS | 3 (1–5)* | 3 (1–5)* | 6 (4–8) | 7 (6–8) | 6 (3–9) | 6 (3–9) |
IIEF-15- Score | 47 (40–54) | 48 (41–55) | 49 (39–60) | 50 (40–60) | 49 (39–59) | 49 (39–59) |